Top 100 Outlook 2021: Medtechs Look To Build On Experiences Of Serving Global Markets In A Pandemic

If necessity is the mother of invention, then medtech firms know what is expected of them in 2021 ̶ how they achieve it might be less straightforward

Medtechs took a long look at themselves as they rose to the challenges of COVID-19. How they responded, repurposed and regrouped to tackle the coronavirus was both sobering and uplifting. The lessons of 2020 must be integrated into the digitally-enabled health care systems of 2021 and beyond.

Outlook for 2021 - Message written on a poster.

COVID-19 has compelled medtech manufacturers, and regulators and governments too, to take a good look at what they do, and assess how they can do it better. Many have also been openly asking why haven’t they done it better. There is nothing like a crisis to focus the mind.

More open regulatory pathways have given medtechs the scope to innovate more rapidly. There are examples aplenty of turbocharged product...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from International

More from Geography